Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-336.49M
↓ 181% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-119.69M
Historical baseline
PeriodValueYoY Change
2025$-336.49M-26.7%
2024$-265.66M-12.9%
2023$-235.37M-82.3%
2022$-129.13M-62.9%
2021$-79.29M-96.8%
2020$-40.28M+1.2%
2019$-40.75M-29.2%
2018$-31.55M-22.2%
2017$-25.82M-106.4%
2016$-12.51M-